ETPN management
After decision of the General Assembly 2017 in Torremolinos – Malaga (Spain), please find below the current composition of the ETPN Executive Board
Last updated: 30.10.2017
ETPN Bureau
Patrick Boisseau
ETPN Chairman
VP HealthTech at CEA Leti, France
Didier Letourneur
ETPN Vice-Chairperson
Director of Research – DR CNRS – INSERM U1148
Laurent Levy
ETPN Vice-Chairperson
CEO Nanobiotix, France
Philippe Mauberna
ETPN Treasurer
CFO at Nanobiotix
ETPN Working group leaders
Eusebio Gainza
W.G. Nanotherapeutics and targeted delivery
R&D Manager, BIOPRAXIS RESEARCH, Spain
Adriele Prina-Mello
W.G. Education & Training
NANOMEDICINE PI at Trinity College Dublin, Ireland
Paul Galvin
W.G. Medical devices
Head of ICT for Health Programmes at Tyndall National Institute
Andreas Falk
W.G. Safety & characterization
CEO at BioNanoNet Forschungsgesellschaft mbH, Austria
Prof. Dr. Hans-Jörg Meisel
W.G. Regenerative Medicine
Director Center of Neurosciences /Neurosurgery, BG-Clinic Bergmannstrost Halle
Klaus-Michael Weltring
A.G. Ethics & Social impact of Nanomedicine
Managing Director, Bioanalytik Muenster, Germany
Pedro Silva
W.G. Business Opporttunities
Technology Transfer Director at Instituto de Medicina Molecular, Lisbon
Olaf Rothaus
Chair of the Mirror Group
EuroNanoMed – Network Steering Commitee Chair, VDI Technologiezentrum GmbH, Germany
ETPN Secretariat operational team
Alexandre Ceccaldi
ETPN General Secretary
Coordinator of the NOBEL Project
Alexandre Superville
Assistant manager of the NOBEL H2020 Project